Literature DB >> 8011568

Study on antihypertensive efficacy of slow-release verapamil: pharmacokinetic and noninvasive hemodynamic profile.

V Vulpis, T M Seccia, S Ricci, P Nazzaro, A Pirrelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8011568     DOI： 10.1007/bf00877724

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN： 0920-3206            Impact factor:   3.727


× No keyword cloud information.
  4 in total

1.  Pharmacokinetics and pharmacodynamics of two formulations of verapamil.

Authors:  K K Hla; J A Henry; A N Latham
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

2.  Age-related antihypertensive and haemodynamic effects of verapamil SR: clinical results and effects on atrial natriuretic peptide.

Authors:  R Antonicelli; P F Tomassini; P Galletti; C Gambini; M Marini; L Amadio; E Paciaroni
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Efficacy of sustained-release verapamil: automatic ambulatory blood pressure monitoring.

Authors:  P K Zachariah; S G Sheps; A Schriger
Journal:  J Clin Hypertens       Date:  1986-09       Impact factor: 3.738

4.  The relationship of dose to the antihypertensive response of verapamil-sustained release in patients with mild to moderate essential hypertension. The Verapamil-SR Study Group.

Authors:  F G McMahon; R F Reder
Journal:  J Clin Pharmacol       Date:  1989-11       Impact factor: 3.126
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.